Nėra interneto ryšio – rodoma išsaugota puslapio versija.

Amgen Inc

USUSD
← Į akcijų filtrą

Amgen Inc (XETRA:AMG) — Biotechnology: Biological Products (No Diagnostic Substances). Biržų, kuriose prekiaujama bendrovės akcijomis, skaičius: 4. Šiame puslapyje — kaina ir grafikas, dividendai, didžiausi akcininkai ir akcijų skaičiaus istorija.

Apie įmonę

Svetainė
amgen.com
Investuotojams
investors.amgen.com/
Sektorius
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Būstinė
Thousand Oaks, United States
Generalinis direktorius
Robert A. Bradway
Darbuotojai
17 900
Įkurta
1980
Biržoje nuo
17.11.1998 (XETRA:AMG)
Apyvartoje esančios akcijos
540.63 mln. 2026-07-30 duomenimis
Laisvai apyvartinės akcijos
539.16 mln.
Rinkos kapitalizacija
226.05 mlrd. USD
Insaideriai
0.23%
Instituciniai investuotojai
85.02%
Šaka (SIC)
Biological Products, (No Diagnostic Substances)
Teisinė forma
XTIQ
ISIN
US0311621009
LEI
62QBXGPJ34PQ72Z12S66
Išmokų santykis
60.4%
FCF
10.2 mlrd. USD
52%
Skola
57.3 mlrd. USD
4.3 m. FCF
Dividendų stažas
15 m.
Pelnas, FCF ir dividendai – už 12 mėnesių iki 30.06.2026 (naujausia įmonės ataskaita).
Aprašymas

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Biržos ir tikeriai

BiržaTikerisValiutaKainaTipas
US USA StocksAMGN pagrindinisUSD407.44 -1.37%paprastosios akcijos
HK Hong Kong Stock Exchange4332 papildomasHKD—
LSE London Stock Exchange0R0T IOBUSD411.854 +1.17%paprastosios akcijos
MX Mexican Stock ExchangeAMGN papildomasMXN7 500.0098 +0.00%paprastosios akcijos
XETRA XetraAMG papildomasEUR367.95 -1.39%paprastosios akcijos

Kaina per 3 mėnesius

kilimo diena kritimo diena dividendų ex data išmokėjimo dataUžveskite / palieskite dieną — atidarymo, uždarymo, aukščiausia ir žemiausia kainos

Dividendai

Per year, US:AMGN: 9.94 USD (4 išm.)

Amgen Inc (AMGN) moka dividendus kas ketvirtį. Per year (12 months up to and including the latest announced payment): 9.94 USD per share (payments: 4). Tai sudaro apie 2.44% dabartinės akcijų kainos. Pagal išmokų istoriją kita ex-dividendų data tikėtina apie 20.11.2026. Nepertraukiamų dividendų metai: 15.

Ex dataIšmokaSuma%TipasTikeris
2026-08-212026-09-112.5200 USD0.6/2.4 %kas ketvirtįUS:AMGN
2026-05-152026-06-052.5200 USD0.6/2.4 %kas ketvirtįUS:AMGN
2026-02-132026-03-062.5200 USD0.6/2.4 %kas ketvirtįUS:AMGN
2025-11-212025-12-122.3800 USD0.6/2.3 %kas ketvirtįUS:AMGN
2025-08-222025-09-122.3800 USD0.6/2.3 %kas ketvirtįUS:AMGN
2025-05-162025-06-062.3800 USD0.6/2.3 %kas ketvirtįUS:AMGN
2025-02-142025-03-072.3800 USD0.6/≈2.3 %kas ketvirtįUS:AMGN
2024-11-182024-12-092.2500 USD0.6/≈2.2 %kas ketvirtįUS:AMGN
2024-08-162024-09-062.2500 USD0.6/≈2.2 %kas ketvirtįUS:AMGN
reklama

Didžiausi akcininkai

TurėtojasDalisAkcijosAtaskaitos data
Blackrock Inc.9.13%49.36 mln.2026-06-30
Vanguard Capital Managem…6.52%35.25 mln.2026-06-30
State Street Corporation5.65%30.56 mln.2026-06-30
Capital World Investors5.38%29.08 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…3.17%17.13 mln.2026-06-30
Invesco Ltd.3.02%16.32 mln.2026-06-30
Geode Capital Management…2.9%15.7 mln.2026-06-30
Charles Schwab Investmen…2.78%15.03 mln.2026-06-30
Vanguard Portfolio Manag…2.75%14.85 mln.2026-06-30
VANGUARD INDEX FUNDS-Van…2.59%13.99 mln.2026-06-30
Morgan Stanley2.53%13.65 mln.2026-06-30
Invesco QQQ Trust, Serie…2.15%11.61 mln.2026-08-31
SCHWAB STRATEGIC TRUST-S…1.81%9.79 mln.2026-05-31
Income Fund of America1.44%7.76 mln.2026-06-30
iShares Trust-iShares Co…1.35%7.28 mln.2026-07-31
Wells Fargo & Company1.34%7.24 mln.2026-06-30
AMERICAN BALANCED FUND1.31%7.09 mln.2026-06-30
Fidelity Concord Street…1.29%6.98 mln.2026-07-31
SPDR S&P 500 ETF TRUST-S…1.22%6.6 mln.2026-08-31
WASHINGTON MUTUAL INVEST…1.16%6.27 mln.2026-06-30
BRADWAY ROBERT A (Chief…≈0.12%657 2992026-05-05
SANTOS ESTEBAN (Officer)≈0.02%84 2792026-05-05
GORDON MURDO (Officer)≈0.01%51 8372026-05-05
GRIFFITH PETER H. (Chief…≈0.01%50 7062026-05-05
REESE DAVID M. (Chief Te…≈0.01%42 8122026-05-05
GRAHAM JONATHAN P (Gener…≈0.01%40 2112026-05-05
BRADNER JAMES E. (Office…≈0.01%30 4622026-05-05
ECKERT ROBERT ANDREW (Di…≈0%26 2512026-05-19
JACKS TYLER (Director)≈0%18 2842026-05-19
KULLMAN ELLEN JAMISON (D…≈0%14 5362026-05-19